Hexa Tradex (HEXATRADEX)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹157.05 |
| Market Cap | ₹867.62 Cr |
| P/E Ratio | 0 |
| ROCE | 0.05% |
| ROE | -0.19% |
| Dividend Yield | 0% |
| Profit Growth | -116.61% |
| Debt/Equity | 0 |
| Sales Growth | -3.1% |
| Promoter Holding | 92.13% |
| 52-Week Range | ₹147.26 — ₹194.89 |
| Sector | Finance |
| Book Value | ₹835.47 |
Strengths
- Trades at a deep discount to book value: P/B of 0.23 against book value of ₹745.50 per share
- Zero debt on the balance sheet, so no leverage risk while waiting for value realization
- ROCE is slightly positive at 0.05%, indicating some residual asset productivity
- Promoter holding of 92.13% suggests no hostile takeover overhang, though it is a double-edged sword
Concerns
- Latest quarter sales are ₹0 with a net loss of ₹4 crore; profit growth is deeply negative at -116.61%
- Return on equity is negative at -0.08%; the company is destroying book value, not building it
- No dividend yield, so minority shareholders receive no current return on their investment
- Piotroski F-Score of 3/9 points to weak financial health and possible asset quality problems
AI Analysis
Let me look at Hexa Tradex the way I look at any business: what does it earn, how strong is its balance sheet, and what are its assets truly worth? At ₹171.50, the market values this investment company at only 23% of its ₹745.50 book value. That is a Graham-style bargain on paper—a deep discount to book with zero debt. But cheap can be an illusion if the assets are not productive. Sales are zero, the latest quarter lost ₹4 crore, profit growth is -116.61%, and return on equity is -0.08%. This is not a compounding machine; it is a holding vehicle. The company isn't earning its keep. No dividend means the minority shareholder gets no check while waiting for value to unlock. ROCE is a measly 0.05%, so the underlying asset base earns almost nothing. With promoter holding at 92.13%, minority investors have little say, and low free float can distort the price. The Piotroski F-score of 3 out of 9 reinforces weak financial health. I would not call this a wonderful business. The potential is that the market is pricing in permanent impairment. Book value may include investments that need to be sold or liquidated; until the company shows realizable value—through dividends, buybacks, or asset sales—the discount may stay, or widen. This is a possible asset play, not a compounder. In Graham's language, it is a special situation: buy something for 23 paise on the rupee of book value, but only if you can identify the exit and trust the stewards. I would need more proof that management is on minority shareholders' side.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer